Top

Published in:

01-09-2011

The LKB1 complex-AMPK pathway: the tree that hides the forest

Authors: Michaël Sebbagh, Sylviane Olschwang, Marie-Josée Santoni, Jean-Paul Borg

Published in: Familial Cancer | Issue 3/2011

Abstract

Initially identified as the Caenorhabditis elegans PAR-4 homologue, the serine threonine kinase LKB1 is conserved throughout evolution and ubiquitously expressed. In humans, LKB1 is causally linked to the Peutz–Jeghers syndrome and is one of the most commonly mutated genes in several cancers like lung and cervical carcinomas. These observations have led to classify LKB1 as tumour suppressor gene. Although, considerable dark zones remain, an impressive leap in the understanding of LKB1 functions has been done during the last decade. Role of LKB1 as a major actor of the AMPK/mTOR pathway connecting cellular metabolism, cell growth and tumorigenesis has been extensively studied probably to the detriment of other functions of equal importance. This review will discuss about LKB1 activity regulation, its effectors and clues on their involvement in cell polarity.

Kemphues KJ, Priess JR, Morton DG, Cheng NS (1988) Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell 52:311–320PubMedCrossRef

Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Muller O, Back W, Zimmer M (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–43PubMedCrossRef

Su JY, Erikson E, Maller JL (1996) Cloning and characterization of a novel serine/threonine protein kinase expressed in early X. embryos. J Biol Chem 271:14430–14437PubMedCrossRef

Denison FC, Hiscock NJ, Carling D, Woods A (2009) Characterization of an alternative splice variant of LKB1. J Biol Chem 284:67–76PubMedCrossRef

Towler MC, Fogarty S, Hawley SA, Pan DA, Martin DM, Morrice NA, McCarthy A, Galardo MN, Meroni SB, Cigorraga SB, Ashworth A, Sakamoto K, Hardie DG (2008) A novel short splice variant of the tumour suppressor LKB1 is required for spermiogenesis. Biochem J 416:1–14PubMedCrossRef

Rowan A, Churchman M, Jefferey R, Hanby A, Poulsom R, Tomlinson I (2000) In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J Pathol 192:203–206PubMedCrossRef

Collins SP, Reoma JL, Gamm DM, Uhler MD (2000) LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 345(Pt 3):673–680PubMedCrossRef

Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184–187PubMedCrossRef

Hemminki A (1999) The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 55:735–750PubMedCrossRef

10.

Olschwang S, Boisson C, Thomas G (2001) Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet 38:356–360PubMedCrossRef

11.

Launonen V (2005) Mutations in the human LKB1/STK11 gene. Hum Mutat 26:291–297PubMedCrossRef

12.

Hastings ML, Resta N, Traum D, Stella A, Guanti G, Krainer AR (2005) An LKB1 AT-AC intron mutation causes Peutz-Jeghers syndrome via splicing at noncanonical cryptic splice sites. Nat Struct Mol Biol 12:54–59PubMedCrossRef

13.

Boudeau J, Scott JW, Resta N, Deak M, Kieloch A, Komander D, Hardie DG, Prescott AR, van Aalten DM, Alessi DR (2004) Analysis of the LKB1-STRAD-MO25 complex. J Cell Sci 117:6365–6375PubMedCrossRef

14.

Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ, Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJ, de Rooij FW, Wilson JH, Hansmann A, Moslein G, Royer-Pokora B, Vogel T, Phillips RK, Spigelman AD, Houlston RS (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12:3209–3215PubMedCrossRef

15.

Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119:1447–1453PubMedCrossRef

16.

Sanchez-Cespedes M (2007) A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26:7825–7832PubMedCrossRef

17.

Morton JP, Jamieson NB, Karim SA, Athineos D, Ridgway RA, Nixon C, McKay CJ, Carter R, Brunton VG, Frame MC, Ashworth A, Oien KA, Evans TR, Sansom OJ (2010) LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest. Gastroenterology 139:586–597PubMedCrossRef

18.

Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM (2002) The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res 8:2085–2090PubMed

19.

Contreras CM, Gurumurthy S, Haynie JM, Shirley LJ, Akbay EA, Wingo SN, Schorge JO, Broaddus RR, Wong KK, Bardeesy N, Castrillon DH (2008) Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. Cancer Res 68:759–766PubMedCrossRef

20.

Kim CJ, Cho YG, Park JY, Kim TY, Lee JH, Kim HS, Lee JW, Song YH, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS (2004) Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer 40:136–141PubMedCrossRef

21.

Ylikorkala A, Rossi DJ, Korsisaari N, Luukko K, Alitalo K, Henkemeyer M, Makela TP (2001) Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 293:1323–1326PubMedCrossRef

22.

Bardeesy N, Sinha M, Hezel AF, Signoretti S, Hathaway NA, Sharpless NE, Loda M, Carrasco DR, DePinho RA (2002) Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419:162–167PubMedCrossRef

23.

McCarthy A, Lord CJ, Savage K, Grigoriadis A, Smith DP, Weigelt B, Reis-Filho JS, Ashworth A (2009) Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation. J Pathol 219:306–316PubMedCrossRef

24.

Hezel AF, Gurumurthy S, Granot Z, Swisa A, Chu GC, Bailey G, Dor Y, Bardeesy N, Depinho RA (2008) Pancreatic lkb1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol 28:2414–2425PubMedCrossRef

25.

Pearson HB, McCarthy A, Collins CM, Ashworth A, Clarke AR (2008) Lkb1 deficiency causes prostate neoplasia in the mouse. Cancer Res 68:2223–2232PubMedCrossRef

26.

Gurumurthy S, Hezel AF, Berger JH, Bosenberg MW, Bardeesy N (2008) LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis. Cancer Res 68:55–63PubMedCrossRef

27.

Granot Z, Swisa A, Magenheim J, Stolovich-Rain M, Fujimoto W, Manduchi E, Miki T, Lennerz JK, Stoeckert CJ Jr, Meyuhas O, Seino S, Permutt MA, Piwnica-Worms H, Bardeesy N, Dor Y (2009) LKB1 regulates pancreatic beta cell size, polarity, and function. Cell Metab 10:296–308PubMedCrossRef

28.

Sun G, Tarasov AI, McGinty JA, French PM, McDonald A, Leclerc I, Rutter GA (2010) LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo. Am J Physiol Endocrinol Metab 298:E1261–E1273PubMedCrossRef

29.

Tamas P, Macintyre A, Finlay D, Clarke R, Feijoo-Carnero C, Ashworth A, Cantrell D (2010) LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells. Eur J Immunol 40:242–253PubMedCrossRef

30.

Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642–1646PubMedCrossRef

31.

Tiainen M, Vaahtomeri K, Ylikorkala A, Makela TP (2002) Growth arrest by the LKB1 tumor suppressor: induction of p21 (WAF1/CIP1). Hum Mol Genet 11:1497–1504PubMedCrossRef

32.

Tiainen M, Ylikorkala A, Makela TP (1999) Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci USA 96:9248–9251PubMedCrossRef

33.

Cheng H, Liu P, Wang ZC, Zou L, Santiago S, Garbitt V, Gjoerup OV, Iglehart JD, Miron A, Richardson AL, Hahn WC, Zhao JJ (2009) SIK1 couples LKB1–p53-dependent anoikis and suppresses metastasis. Sci Signal 2:Ra 35

34.

Karuman P, Gozani O, Odze RD, Zhou XC, Zhu H, Shaw R, Brien TP, Bozzuto CD, Ooi D, Cantley LC, Yuan J (2001) The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 7:1307–1319PubMedCrossRef

35.

Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, Slingerland JM, Mills GB (2007) The energy sensing LKB1-AMPK pathway regulates p27 (kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9:218–224PubMedCrossRef

36.

Shackelford DB, Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9:563–575PubMedCrossRef

37.

Forcet C, Etienne-Manneville S, Gaude H, Fournier L, Debilly S, Salmi M, Baas A, Olschwang S, Clevers H, Billaud M (2005) Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity. Hum Mol Genet 14:1283–1292PubMedCrossRef

38.

Zhang S, Schafer-Hales K, Khuri FR, Zhou W, Vertino PM, Marcus AI (2008) The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity. Cancer Res 68:740–748PubMedCrossRef

39.

Baas AF, Kuipers J, van der Wel NN, Batlle E, Koerten HK, Peters PJ, Clevers HC (2004) Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116:457–466PubMedCrossRef

40.

Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Makela TP, Hardie DG, Alessi DR (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23:833–843PubMedCrossRef

41.

Al-Hakim AK, Goransson O, Deak M, Toth R, Campbell DG, Morrice NA, Prescott AR, Alessi DR (2005) 14–3–3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J Cell Sci 118:5661–5673PubMedCrossRef

42.

Baas AF, Boudeau J, Sapkota GP, Smit L, Medema R, Morrice NA, Alessi DR, Clevers HC (2003) Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 22:3062–3072PubMedCrossRef

43.

Boudeau J, Baas AF, Deak M, Morrice NA, Kieloch A, Schutkowski M, Prescott AR, Clevers HC, Alessi DR (2003) MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 22:5102–5114PubMedCrossRef

44.

Zeqiraj E, Filippi BM, Deak M, Alessi DR, van Aalten DM (2009) Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science 326:1707–1711PubMedCrossRef

45.

Marignani PA, Scott KD, Bagnulo R, Cannone D, Ferrari E, Stella A, Guanti G, Simone C, Resta N (2007) Novel splice isoforms of STRADalpha differentially affect LKB1 activity, complex assembly and subcellular localization. Cancer Biol Ther 6:1627–1631PubMedCrossRef

46.

Sanna MG, da Silva Correia J, Luo Y, Chuang B, Paulson LM, Nguyen B, Deveraux QL, Ulevitch RJ (2002) ILPIP: a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosis. J Biol Chem 277:30454–30462PubMedCrossRef

47.

Sapkota GP, Deak M, Kieloch A, Morrice N, Goodarzi AA, Smythe C, Shiloh Y, Lees-Miller SP, Alessi DR (2002) Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366. Biochem J 368:507–516PubMedCrossRef

48.

Sherman MH, Kuraishy AI, Deshpande C, Hong JS, Cacalano NA, Gatti RA, Manis JP, Damore MA, Pellegrini M, Teitell MA (2010) AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling. Mol Cell 39:873–885PubMedCrossRef

49.

Sapkota GP, Kieloch A, Lizcano JM, Lain S, Arthur JS, Williams MR, Morrice N, Deak M, Alessi DR (2001) Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90 (RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth. J Biol Chem 276:19469–19482PubMedCrossRef

50.

Zheng B, Jeong JH, Asara JM, Yuan YY, Granter SR, Chin L, Cantley LC (2009) Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol Cell 33:237–247PubMedCrossRef

51.

Fogarty S, Hardie DG (2009) C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest. J Biol Chem 284:77–84PubMedCrossRef

52.

Sapkota GP, Boudeau J, Deak M, Kieloch A, Morrice N, Alessi DR (2002) Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome. Biochem J 362:481–490PubMedCrossRef

53.

Sebbagh M, Santoni MJ, Hall B, Borg JP, Schwartz MA (2009) Regulation of LKB1/STRAD localization and function by E-cadherin. Curr Biol 19:37–42PubMedCrossRef

54.

Martin SG, St Johnston D (2003) A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature 421:379–384PubMedCrossRef

55.

Lan F, Cacicedo JM, Ruderman N, Ido Y (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283:27628–27635PubMedCrossRef

56.

Dorfman J, Macara IG (2008) STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7. Mol Biol Cell 19:1614–1626PubMedCrossRef

57.

Nezu J, Oku A, Shimane M (1999) Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients. Biochem Biophys Res Commun 261:750–755PubMedCrossRef

58.

Smith DP, Spicer J, Smith A, Swift S, Ashworth A (1999) The mouse Peutz-Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase. Hum Mol Genet 8:1479–1485PubMedCrossRef

59.

Narbonne P, Hyenne V, Li S, Labbe JC, Roy R (2010) Differential requirements for STRAD in LKB1-dependent functions in C. elegans. Development 137:661–670PubMedCrossRef

60.

Mirouse V, Swick LL, Kazgan N, Johnston D, Brenman JE (2007) LKB1 and AMPK maintain epithelial cell polarity under energetic stress. J Cell Biol 177:387–392PubMedCrossRef

61.

Boehlke C, Kotsis F, Patel V, Braeg S, Voelker H, Bredt S, Beyer T, Janusch H, Hamann C, Godel M, Muller K, Herbst M, Hornung M, Doerken M, Kottgen M, Nitschke R, Igarashi P, Walz G, Kuehn EW (2010) Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat Cell Biol 12:1115–1122PubMedCrossRef

62.

Boudeau J, Deak M, Lawlor MA, Morrice NA, Alessi DR (2003) Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem J 370:849–857PubMedCrossRef

63.

Nony P, Gaude H, Rossel M, Fournier L, Rouault JP, Billaud M (2003) Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37. Oncogene 22:9165–9175PubMedCrossRef

64.

Smith DP, Rayter SI, Niederlander C, Spicer J, Jones CM, Ashworth A (2001) LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. Hum Mol Genet 10:2869–2877PubMedCrossRef

65.

Mehenni H, Lin-Marq N, Buchet-Poyau K, Reymond A, Collart MA, Picard D, Antonarakis SE (2005) LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Hum Mol Genet 14:2209–2219PubMedCrossRef

66.

Merg A, Howe JR (2004) Genetic conditions associated with intestinal juvenile polyps. Am J Med Genet C Semin Med Genet 129C:44–55PubMedCrossRef

67.

Nath-Sain S, Marignani PA (2009) LKB1 catalytic activity contributes to estrogen receptor alpha signaling. Mol Biol Cell 20:2785–2795PubMedCrossRef

68.

Marignani PA, Kanai F, Carpenter CL (2001) LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J Biol Chem 276:32415–32418PubMedCrossRef

69.

Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13:2004–2008PubMedCrossRef

70.

Hong SP, Leiper FC, Woods A, Carling D, Carlson M (2003) Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc Natl Acad Sci USA 100:8839–8843PubMedCrossRef

71.

Scott JW, Hawley SA, Green KA, Anis M, Stewart G, Scullion GA, Norman DG, Hardie DG (2004) CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 113:274–284PubMed

72.

Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9–22PubMedCrossRef

73.

Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA (2005) The Ca²⁺/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280:29060–29066PubMedCrossRef

74.

Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, Mann DL, Taffet GE, Baldini A, Khoury DS, Schneider MD (2006) A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA 103:17378–17383PubMedCrossRef

75.

Barnes AP, Lilley BN, Pan YA, Plummer LJ, Powell AW, Raines AN, Sanes JR, Polleux F (2007) LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell 129:549–563PubMedCrossRef

76.

Kishi M, Pan YA, Crump JG, Sanes JR (2005) Mammalian SAD kinases are required for neuronal polarization. Science 307:929–932PubMedCrossRef

77.

Alvarado-Kristensson M, Rodriguez MJ, Silio V, Valpuesta JM, Carrera AC (2009) SADB phosphorylation of gamma-tubulin regulates centrosome duplication. Nat Cell Biol 11:1081–1092PubMedCrossRef

78.

Fujimoto T, Yurimoto S, Hatano N, Nozaki N, Sueyoshi N, Kameshita I, Mizutani A, Mikoshiba K, Kobayashi R, Tokumitsu H (2008) Activation of SAD kinase by Ca²⁺/calmodulin-dependent protein kinase kinase. Biochemistry 47:4151–4159PubMedCrossRef

79.

Cohen D, Brennwald PJ, Rodriguez-Boulan E, Musch A (2004) Mammalian PAR-1 determines epithelial lumen polarity by organizing the microtubule cytoskeleton. J Cell Biol 164:717–727PubMedCrossRef

80.

Suzuki A, Hirata M, Kamimura K, Maniwa R, Yamanaka T, Mizuno K, Kishikawa M, Hirose H, Amano Y, Izumi N, Miwa Y, Ohno S (2004) aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr Biol 14:1425–1435PubMedCrossRef

81.

Timm T, Li XY, Biernat J, Jiao J, Mandelkow E, Vandekerckhove J, Mandelkow EM (2003) MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J 22:5090–5101PubMedCrossRef

82.

Kojima Y, Miyoshi H, Clevers HC, Oshima M, Aoki M, Taketo MM (2007) Suppression of tubulin polymerization by the LKB1-microtubule-associated protein/microtubule affinity-regulating kinase signaling. J Biol Chem 282:23532–23540PubMedCrossRef

83.

Bettencourt-Dias M, Giet R, Sinka R, Mazumdar A, Lock WG, Balloux F, Zafiropoulos PJ, Yamaguchi S, Winter S, Carthew RW, Cooper M, Jones D, Frenz L, Glover DM (2004) Genome-wide survey of protein kinases required for cell cycle progression. Nature 432:980–987PubMedCrossRef

84.

Takemori H, Doi J, Horike N, Katoh Y, Min L, Lin XZ, Wang ZN, Muraoka M, Okamoto M (2003) Salt-inducible kinase-mediated regulation of steroidogenesis at the early stage of ACTH-stimulation. J Steroid Biochem Mol Biol 85:397–400PubMedCrossRef

85.

Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR III, Takemori H, Okamoto M, Montminy M (2004) The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119:61–74PubMedCrossRef

86.

Tsuchihara K, Ogura T, Fujioka R, Fujii S, Kuga W, Saito M, Ochiya T, Ochiai A, Esumi H (2008) Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci. Cancer Sci 99:677–682PubMedCrossRef

87.

Yamamoto H, Takashima S, Shintani Y, Yamazaki S, Seguchi O, Nakano A, Higo S, Kato H, Liao Y, Asano Y, Minamino T, Matsumura Y, Takeda H, Kitakaze M (2008) Identification of a novel substrate for TNFalpha-induced kinase NUAK2. Biochem Biophys Res Commun 365:541–547PubMedCrossRef

88.

Zagorska A, Deak M, Campbell DG, Banerjee S, Hirano M, Aizawa S, Prescott AR, Alessi DR (2010) New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci Signal 3:ra 25CrossRef

89.

Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi H (2004) ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol 24:3526–3535PubMedCrossRef

90.

Humbert N, Navaratnam N, Augert A, Da Costa M, Martien S, Wang J, Martinez D, Abbadie C, Carling D, de Launoit Y, Gil J, Bernard D (2010) Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J 29:376–386PubMedCrossRef

91.

Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, Ochiai A, Esumi H (2004) Regulation of caspase-6 and FLIP by the AMPK family member ARK5. Oncogene 23:7067–7075PubMedCrossRef

92.

Hebert M, Potin S, Sebbagh M, Bertoglio J, Breard J, Hamelin J (2008) Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells. J Immunol 181:5963–5973PubMed

93.

Jaleel M, McBride A, Lizcano JM, Deak M, Toth R, Morrice NA, Alessi DR (2005) Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate. FEBS Lett 579:1417–1423PubMedCrossRef

94.

Sakamoto K, McCarthy A, Smith D, Green KA, Grahame Hardie D, Ashworth A, Alessi DR (2005) Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24:1810–1820PubMedCrossRef

95.

Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190–193PubMedCrossRef

96.

Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118–132PubMedCrossRef

97.

Zhang L, Li J, Young LH, Caplan MJ (2006) AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc Natl Acad Sci USA 103:17272–17277PubMedCrossRef

98.

Zheng B, Cantley LC (2007) Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. Proc Natl Acad Sci USA 104:819–822PubMedCrossRef

99.

Caudron F, Barral Y (2009) Septins and the lateral compartmentalization of eukaryotic membranes. Dev Cell 16:493–506PubMedCrossRef

100.

Shao J, Evers BM, Sheng H (2004) Roles of phosphatidylinositol 3’-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res 64:229–235PubMedCrossRef

Title: The LKB1 complex-AMPK pathway: the tree that hides the forest
Authors: Michaël Sebbagh
Sylviane Olschwang
Marie-Josée Santoni
Jean-Paul Borg
Publication date: 01-09-2011
Publisher: Springer Netherlands
Published in: Familial Cancer / Issue 3/2011
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-011-9457-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

The role of LKB1 in lung cancer

Factors associated with an individuals’ decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?

Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer

A rationale for mTOR inhibitors as chemoprevention agents in Peutz-Jeghers syndrome

Familial breast cancer: is it time to move from a reactive to a proactive role?

Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch Syndrome

Keynote webinar | Spotlight on antibody–drug conjugates in cancer